STRM — Streamline Health Solutions Share Price
- $13.87m
- $22.80m
- $22.60m
- 33
- 63
- 47
- 45
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.87 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.68 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -69.89% | ||
Return on Equity | -80.09% | ||
Operating Margin | -91.22% |
Financial Summary
Year End 31st Jan | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 11.85 | 11.35 | 17.38 | 24.89 | 22.6 | 20.01 | 20.82 | 0.21% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Streamline Health Solutions, Inc. enables healthcare organizations to proactively address revenue leakage and improve financial performance. The Company delivers integrated solutions, technology-enabled services and analytics. It operates in one segment as a provider of health information technology solutions and associated services that improve healthcare processes and information flows within a healthcare facility. The Company sells its solutions and services in North America to hospitals and health systems through its direct sales force and its reseller partnerships. It offers solutions and services to assist its clients in revenue cycle management, including its two flagship technologies: RevIDTM and eValuatorTM. RevID offers automated, daily reconciliation of clinical event activity to patient billing charge items prior to billing. eValuator provides 100% automated coding analysis prior to billing. It offers an array of professional services, including system implementation.
Directors
- Jonathan Phillips NEC (47)
- Wyche Green PRE (49)
- Thomas Gibson CFO (57)
- William Garvis COO (53)
- Randolph Salisbury SVP (67)
- Justin Ferayorni IND (47)
- Kenan Lucas IND (35)
- Judith Starkey IND (71)
- Last Annual
- January 31st, 2024
- Last Interim
- July 31st, 2024
- Incorporated
- February 7th, 1996
- Public Since
- April 18th, 1996
- No. of Shareholders
- 215
- No. of Employees
- 77
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 63,324,103
- Address
- 2400 Old Milton Parkway, Box 1353, ALPHARETTA, 30009
- Web
- https://www.streamlinehealth.net/
- Phone
- +1 4044462051
- Contact
- Jacob Goldberger
- Auditors
- FORVIS, LLP
Upcoming Events for STRM
Q3 2024 Streamline Health Solutions Inc Earnings Release
Similar to STRM
23andMe Holding Co.
NASDAQ Capital Market
ADVANCED BIOMED
NASDAQ Capital Market
Akanda
NASDAQ Capital Market
Astrana Health
NASDAQ Capital Market
Avalon Globocare
NASDAQ Capital Market
FAQ
As of Today at 23:56 UTC, shares in Streamline Health Solutions are trading at $0.22. This share price information is delayed by 15 minutes.
Shares in Streamline Health Solutions last closed at $0.22 and the price had moved by -75.31% over the past 365 days. In terms of relative price strength the Streamline Health Solutions share price has underperformed the S&P500 Index by -80.47% over the past year.
The overall consensus recommendation for Streamline Health Solutions is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreStreamline Health Solutions does not currently pay a dividend.
Streamline Health Solutions does not currently pay a dividend.
Streamline Health Solutions does not currently pay a dividend.
To buy shares in Streamline Health Solutions you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.22, shares in Streamline Health Solutions had a market capitalisation of $13.87m.
Here are the trading details for Streamline Health Solutions:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: STRM
Based on an overall assessment of its quality, value and momentum Streamline Health Solutions is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Streamline Health Solutions is $1.50. That is 584.93% above the last closing price of $0.22.
Analysts covering Streamline Health Solutions currently have a consensus Earnings Per Share (EPS) forecast of -$0.13 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Streamline Health Solutions. Over the past six months, its share price has underperformed the S&P500 Index by -62.18%.
As of the last closing price of $0.22, shares in Streamline Health Solutions were trading -49.62% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Streamline Health Solutions PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.22.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Streamline Health Solutions' management team is headed by:
- Jonathan Phillips - NEC
- Wyche Green - PRE
- Thomas Gibson - CFO
- William Garvis - COO
- Randolph Salisbury - SVP
- Justin Ferayorni - IND
- Kenan Lucas - IND
- Judith Starkey - IND